The high rates of DM remission, in conjunction with the risk of post-operative hypoglycemia principally due to excessive rebound hyperinsulinemia require vigorous glucose monitoring post-operatively and appropriate down-titration of anti-diabetic regimens, especially in insulin-treated patients [82, 92]. The gene discussed is INS; the disease is hyperinsulinism.